相关实验视频
Updated: Jul 13, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
111.8K
自然化合物:Wnt途径抑制剂,在肺癌中具有治疗潜力
Xuetong Shen1, Chundi Gao2, Huayao Li2
1College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in pharmacology
|October 16, 2023
概括
天然产品在向肺癌中的Wnt/β-catenin通路方面显示出有前途. 这些化合物为开发更安全,更有效的肺癌治疗提供了多样化,低毒性的替代品.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺癌中Wnt/β-catenin通路经常过度激活,导致癌症发生,进展和治疗耐药性.
- 向这种途径具有治疗潜力,但由于途径的复杂性,瘤异质性和非向效应而面临挑战.
研究的目的:
- 审查针对肺癌中Wnt/β-catenin通路的化合物,特别是天然产品的研究.
- 探索开发更安全,更有针对性的肺癌治疗方法.
主要方法:
- 对研究自然产品及其衍生物的文献综述.
- 分析这些化合物抑制Wnt/β-catenin通路的机制.
- 临床前抗瘤疗效和毒性概况的评估.
主要成果:
- 各种天然产品通过各种上游和下游机制抑制Wnt/β-catenin信号传递.
- 这些天然化合物显示出有希望的临床前抗瘤活性,对抗肺癌.
- 与传统的Wnt抑制剂相比,天然产品具有有利的毒性概况.
结论:
- 自然产品是开发针对Wnt/β-catenin通路的新型肺癌治疗的可行策略.
- 它们的多样性和低毒性支持它们在组合疗法和未来药物开发中的潜力.
更多相关视频
相关概念视频
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K

